Cargando…

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022

Detalles Bibliográficos
Autor principal:	Maeurer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644748/ https://www.ncbi.nlm.nih.gov/pubmed/38022607 http://dx.doi.org/10.3389/fimmu.2023.1311519

Ejemplares similares

Editorial: Emerging talents in comparative immunology: 2022
por: Liu, Yan-Jun, et al.
Publicado: (2023)

Editorial: Emerging talents in pediatric endocrinology: 2022
por: Staels, Willem, et al.
Publicado: (2023)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
por: Khan, Husain Yar, et al.
Publicado: (2023)

Editorial: Emerging talents in pharmacology of ion channels and channelopathies 2022
por: Yakubovich, Daniel
Publicado: (2023)

Editorial: Emerging talents in human neuroscience: Cognitive neuroscience 2022
por: Hélie, Sébastien
Publicado: (2023)

Editorial: Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022
por: Klomp, Sylvia D., et al.
Publicado: (2023)

Editorial: Emerging talents in pharmacology: Drugs outcomes research and policies 2022
por: Linger, Rachel M. A., et al.
Publicado: (2023)

Editorial: Emerging talents in Frontiers in Pharmacology: Drug metabolism and transport 2022
por: Hinds, Terry D., et al.
Publicado: (2022)

Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022
por: Grasa, Laura, et al.
Publicado: (2022)

Editorial: Emerging talents in: sleep disorders
por: Thannickal, Thomas Chacko, et al.
Publicado: (2023)

Editorial: Emerging talents in clinical diabetes
por: Matafome, Paulo, et al.
Publicado: (2023)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023)

Editorial: Overcoming challenges in mucosal immunity: 2022
por: Leceta, Javier, et al.
Publicado: (2023)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Emerging talents in genomic assay technology
por: Reddi, Honey V., et al.
Publicado: (2023)

Editorial: Insights in cytokines and soluble mediators in immunity: 2022
por: Melgrati, Serena, et al.
Publicado: (2023)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023)

Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy
por: Dai, Xiangpeng, et al.
Publicado: (2022)

Editorial: Expert opinions and perspectives in immunity to worms infection: 2022
por: Fonte, Luis, et al.
Publicado: (2023)

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy
por: Nunès, Jacques A., et al.
Publicado: (2023)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Editorial: Non-coding RNA in immunotherapies and immune regulation
por: Kaeffer, Bertrand, et al.
Publicado: (2022)

Editorial: Peptide-based immunotherapy against emerging viral infections
por: Jiang, Shisong
Publicado: (2023)

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
por: Lafont, Virginie, et al.
Publicado: (2021)

Editorial: Insights in inflammation: 2022
por: Ghezzi, Pietro, et al.
Publicado: (2023)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
por: Dai, Weijing, et al.
Publicado: (2022)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
por: Tan, Ruirong, et al.
Publicado: (2023)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Editorial: Interplay between oncomicrobes, the microbiota and the immune system: impact on responses to cancer immunotherapy
por: Dorta-Estremera, Stephanie M., et al.
Publicado: (2023)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
por: Roy, Dia, et al.
Publicado: (2023)

Editorial: Insights in microbial immunology: 2022
por: Marriott, Ian, et al.
Publicado: (2023)

Editorial: Methods in T cell biology: 2022
por: Aguado, Enrique, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4jtebshko55ht7m6vbln1hopn0